Sofosbuvir, sold under the brand name Sovaldi among others, is a medication used to treat hepatitis C. It is taken by mouth. Common side effects include...
64 KB (5,828 words) - 23:44, 21 October 2024
Sofosbuvir/velpatasvir, sold under the brand name Epclusa among others, is a fixed-dose combination medication for the treatment of hepatitis C in adults...
14 KB (1,161 words) - 05:20, 7 April 2024
Ledipasvir/sofosbuvir, sold under the trade name Harvoni among others, is a medication used to treat hepatitis C. It is a fixed-dose combination of ledipasvir...
22 KB (1,936 words) - 20:18, 6 November 2024
Daclatasvir/sofosbuvir (trade names Darvoni, Sovodak) is a two-drug combination for the treatment of hepatitis C. It is given as a single daily pill containing...
8 KB (741 words) - 14:59, 24 January 2024
blood) or 12 weeks of elbasvir/grazoprevir, ledipasvir/sofosbuvir, or sofosbuvir/velpatasvir. Sofosbuvir with either daclatasvir or simeprevir may also be...
109 KB (11,864 words) - 01:35, 14 November 2024
Sofosbuvir/velpatasvir/voxilaprevir, sold under the brand name Vosevi, is a fixed-dose combination medication for the treatment of hepatitis C. It contains...
9 KB (495 words) - 13:47, 7 September 2024
Daclatasvir/sofosbuvir (daclatasvir + sofosbuvir) Glecaprevir/pibrentasvir (glecaprevir + pibrentasvir) Ravidasvir Sofosbuvir Sofosbuvir/velpatasvir (sofosbuvir +...
67 KB (4,835 words) - 08:21, 11 November 2024
available products include velpatasvir/sofosbuvir, sofosbuvir/daclatasvir, osimertinib, crizotinib, daclatasvir, sofosbuvir, afatinib, axitinib, brigatinib,...
5 KB (232 words) - 10:23, 8 March 2024
S. approval of a ledipasvir/sofosbuvir fixed-dose combination tablet for genotype 1 hepatitis C. The ledipasvir/sofosbuvir combination is a direct-acting...
11 KB (718 words) - 00:55, 14 November 2024
investigating the use of the "government patent use" as a strategy, to make Sofosbuvir, manufactured by Gilead Sciences, a highly effective treatment for Hepatitis...
11 KB (1,080 words) - 12:29, 15 June 2024